Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Jarzebska

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 9, 2022
COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 2, 2022
Correction: COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Trends in Pharmacological Sciences|October 9, 2014
AGXT2: a promiscuous aminotransferaseRoman N Rodionov, Natalia Jarzebska, Norbert Weiss, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 16, 2021
Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data AnalysisRoman N Rodionov, Frederik Peters, Ursula Marschall, et al.
Nutrients|March 3, 2019
Beta-Aminoisobutyric Acid as a Novel Regulator of Carbohydrate and Lipid MetabolismDmitrii A Tanianskii, Natalia Jarzebska, Andreas L Birkenfeld, et al.
International Journal of Molecular Sciences|September 20, 2019
The Second Life of Methylarginines as Cardiovascular TargetsNatalia Jarzebska, Arduino A Mangoni, Jens Martens-Lobenhoffer, et al.
American Journal of Physiology. Renal Physiology|June 20, 2014
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertensionFlorian Gembardt, Christoph Bartaun, Natalia Jarzebska, et al.
Frontiers in Medicine|February 1, 2021
Scarred Lung. An Update on Radiation-Induced Pulmonary FibrosisNatalia Jarzebska, Ekaterina S Karetnikova, Alexander G Markov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 15, 2019
Is Homoarginine a Protective Cardiovascular Risk Factor?Ekaterina S Karetnikova, Natalia Jarzebska, Alexander G Markov, et al.
Nutrients|May 28, 2020
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms-A Narrative ReviewJibran A Wali, Natalia Jarzebska, David Raubenheimer, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 9, 2022
COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 2, 2022
Correction: COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Trends in Pharmacological Sciences|October 9, 2014
AGXT2: a promiscuous aminotransferaseRoman N Rodionov, Natalia Jarzebska, Norbert Weiss, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 16, 2021
Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data AnalysisRoman N Rodionov, Frederik Peters, Ursula Marschall, et al.
Nutrients|March 3, 2019
Beta-Aminoisobutyric Acid as a Novel Regulator of Carbohydrate and Lipid MetabolismDmitrii A Tanianskii, Natalia Jarzebska, Andreas L Birkenfeld, et al.
International Journal of Molecular Sciences|September 20, 2019
The Second Life of Methylarginines as Cardiovascular TargetsNatalia Jarzebska, Arduino A Mangoni, Jens Martens-Lobenhoffer, et al.
American Journal of Physiology. Renal Physiology|June 20, 2014
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertensionFlorian Gembardt, Christoph Bartaun, Natalia Jarzebska, et al.
Frontiers in Medicine|February 1, 2021
Scarred Lung. An Update on Radiation-Induced Pulmonary FibrosisNatalia Jarzebska, Ekaterina S Karetnikova, Alexander G Markov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 15, 2019
Is Homoarginine a Protective Cardiovascular Risk Factor?Ekaterina S Karetnikova, Natalia Jarzebska, Alexander G Markov, et al.
Nutrients|May 28, 2020
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms-A Narrative ReviewJibran A Wali, Natalia Jarzebska, David Raubenheimer, et al.
Pageof 4